New 1,2,4‐Triazole Scaffolds as Anticancer Agents: Synthesis, Biological Evaluation and Docking Studies
- 12 July 2021
- journal article
- research article
- Published by Wiley in ChemistrySelect
- Vol. 6 (26), 6788-6796
- https://doi.org/10.1002/slct.202101387
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Synthesis and antimicrobial activity of some novel substituted 1,2,4‐triazoles bearing 1,3,4‐oxadiazoles or pyrazolesJournal of Heterocyclic Chemistry, 2011
- Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives of isoniazidBioorganic & Medicinal Chemistry Letters, 2010
- Synthesis of 3,4,5-Trisubstituted-1,2,4-triazolesChemical Reviews, 2010
- PTEN and the PI3-Kinase Pathway in CancerAnnual review of pathology, 2009
- 1,3,4-Oxadiazole/thiadiazole and 1,2,4-triazole derivatives of biphenyl-4-yloxy acetic acid: Synthesis and preliminary evaluation of biological propertiesEuropean Journal of Medicinal Chemistry, 2008
- The E Factor: fifteen years onGreen Chemistry, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Synthesis and antimicrobial evaluation of some 1,2,4‐triazole, 1,3,4‐oxa(thia)diazole, and 1,2,4‐triazolo[3,4‐b]‐1,3,4‐thiadiazine derivativesHeteroatom Chemistry, 2005
- The role of the medicinal chemist in drug discovery — then and nowNature Reviews Drug Discovery, 2004
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002